XTL Biopharmaceuticals Ltd. (XTLB)

1.03 -0.04 (-3.74%) USD  |  NASDAQ  |  Feb 09, 10:18
More

XTL Biopharmaceuticals EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for XTLB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Compugen Ltd. Upgrade
Pluri, Inc. Upgrade
BioLineRx Ltd. Upgrade
Can-Fite BioPharma Ltd. --
Evogene Ltd. Upgrade